Recent studies reported different biomarkers associated with the occurrence of CRS and/or ICANS, such as lactate dehydrogenase (LDH), as marker for tumor burden, the inflammatory markers C-reactive protein (CRP) and ferritin, and platelet count as an indicator for hematopoietic reserve [8,9,10]. The gene discussed is CRP; the disease is congenital rubella syndrome.